| Literature DB >> 27811945 |
Yun Zhang1, Yun Xu1, Shuwan Liu1, Xiaohong Guo1, Dong Cen1, Jiaqi Xu1, Heyuan Li1, Kaijun Li2, Chunlai Zeng2, Linrong Lu3, Yiting Zhou4, Huahao Shen5, Hongqiang Cheng1,6, Xue Zhang1,6, Yuehai Ke1,6.
Abstract
Asthma is a common allergic disorder involving a complex interplay among multiple genetic and environmental factors. Recent studies identified genetic variants of human GAB1 as a novel asthma susceptibility factor. However, the functions of Gab1 in lung remain largely unexplored. In this study, we first observed an elevation of Gab1 level in peripheral blood mononuclear cells from asthmatic patients during acute exacerbation compared with convalescence. Mice with a selectively disrupted Gab1 in myeloid dendritic cells (mDCs) considerably attenuated allergic inflammation in experimental models of asthma. Further investigations revealed a prominent reduction in CCL19-mediated migration of Gab1-deficient mDCs to draining lymph nodes and subsequent impairment of Th2-driven adaptive activation. Mechanistically, Gab1 is an essential component of the CCL19/CCR7 chemokine axis that regulates mDC migration during asthmatic responses. Together, these findings provide the first evidence for the roles of Gab1 in lung, giving us deeper understanding of asthmatic pathogenesis.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27811945 PMCID: PMC5099873 DOI: 10.1038/cr.2016.124
Source DB: PubMed Journal: Cell Res ISSN: 1001-0602 Impact factor: 25.617